SPANDOW OLIVER J. purchased 10.5% of their position (1.50K shares) of NEPHROS INC on the open market
Open‑market purchase worth $8.7K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/20/2020ACC: 0000914190-20-000423
+1.50K
Net shares
Net buyer
$8.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.50K
Price / share
$5.83
Trade value
$8.75K
% of position
10.5%
11/18/2020
14.23K→15.73K
Total
Net shares
+1.50K
Net value
$8.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/18/2020 | P · Purchase | +1.50K | $5.83 | $8.75K | 10.5% | 14.23K | 15.73K |
| Total | +1.50K | $8.75K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)3
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
5.16K
Shares owned
5.16K
Exercise price
5.85
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
9.47K
Shares owned
9.47K
Exercise price
5.5755
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
5.57K
Shares owned
5.57K
Exercise price
8.57
Expiration
—
Exercise window
—
Total
Underlying
20.20K
Owned
20.20K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 5.85 | — | — | 5.16K | 5.16K |
| Stock Option (Right to Buy) Direct | Common Stock | 5.5755 | — | — | 9.47K | 9.47K |
| Stock Option (Right to Buy) Direct | Common Stock | 8.57 | — | — | 5.57K | 5.57K |
| Total | 20.20K | 20.20K | ||||